BioSpace News Archive

BioCapital

Genseq Selects Sapio LIMS to Power Best-in-Class Next-Generation Sequencing Services

Genseq, a Dublin-based, CAP-accredited laboratory providing a range of services for biopharma and clinical research, has adopted the science-aware™ lab informatics platform from Sapio Sciences to manage its next-generation sequencing and biobanking workflows.

March 18, 2024
·
3 min read
Biotech Bay

ConKay Medical Systems Raises $1.8M in Oversubscribed Seed Funding Round

ConKay Medical Systems, a medtech start-up company developing a unique device for treating patients suffering from valvular regurgitation, has closed an oversubscribed $1.8M seed round.

March 18, 2024
·
2 min read
Business

GRO Biosciences Expands Executive Team with Appointment of Biopharma Veteran Tracey Lodie, PhD as Chief Development Officer

GRO Biosciences Inc., an emerging biotechnology company leveraging synthetic biology to expand the amino acid alphabet and deliver on the promise of protein therapeutics, announced the expansion of its leadership with the hire of Tracey Lodie, PhD as Chief Development Officer.

March 18, 2024
·
3 min read
BioMidwest

First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference

First Wave BioPharma, Inc., announced that two abstracts have been accepted for presentation at the 2024 Digestive Disease Week Conference taking place May 18-21, 2024, in Washington, D.C.

March 18, 2024
·
6 min read
Business

Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

Acurx Pharmaceuticals, Inc. announced certain financial and operational results for the fourth quarter and full year ended December 31, 2023.

March 18, 2024
·
10 min read
Genetown

Global Patient Survey Results Reveal Significant Negative Impact on Social, Emotional and Mental Well-Being for People Living with Low-Grade Serous Ovarian Cancer

Verastem Oncology announced new results from the first-ever global LGSOC Patient Impact Survey, developed with patient advocates and community medical leaders to better understand and address the complex needs and experiences of those living with low-grade serous ovarian cancer.

March 18, 2024
·
7 min read
Drug Development

Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion

Oragenics, Inc. announced it has appointed Dr. James “Jim” Kelly, Neurologist, as its Chief Medical Officer, to oversee its upcoming Phase II clinical trial.

March 18, 2024
·
6 min read
Business

Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer

Orthofix Medical Inc., a leading global spine and orthopedics company, announced that Lucas Vitale has joined the company in the newly created role of Chief People and Business Operations Officer.

March 18, 2024
·
5 min read
Business

Zevra Therapeutics to Report 2023 Fourth Quarter and Full Year Financial Results on March 28, 2024

Zevra Therapeutics, Inc. today announced that it will host a conference call and live audio webcast on Thursday, March 28, 2024, at 4:30 p.m. ET, to review its corporate and financial results for the fourth quarter and full year 2023.

March 18, 2024
·
2 min read
Biotech Bay

Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options

Mainz Biomed N.V. will host an educational webinar on Early Detection of Colorectal Cancer: New Laboratory Diagnostic Options which is taking place on March 20, 2024.

March 18, 2024
·
5 min read